Oder Investment Management’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$570K Buy
13,572
+1,169
+9% +$49.4K 0.37% 69
2026
Q2
$511K Buy
+12,403
New +$470K 0.34% 77

Other funds holding CANC

Oder Investment Management's CANC Position: Q3 2026 in Review

Oder Investment Management increased its Tema Oncology ETF (CANC) stake by 9.4% in Q3 2026, buying an estimated $49.4K and bringing the position to 13,572 shares worth $570K. The position accounts for 0.37% of the portfolio, ranked #69.

Oder Investment Management first reported a position in CANC in Q2 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.

  • Oder Investment Management held 13,572 shares of Tema Oncology ETF worth $570K as of Q3 2026.
  • Oder Investment Management bought 1,169 Tema Oncology ETF shares in Q3 2026, an estimated $49.4K.
  • Tema Oncology ETF made up 0.37% of Oder Investment Management's portfolio in Q3 2026, its #69 holding.
  • Oder Investment Management first reported a position in Tema Oncology ETF in Q2 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.

Based on Oder Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.